General Archive

-

Translational Innovation Hub Network for Lung Health and Infection in Cystic Fibrosis project page
Translational Innovation Hub Network for Lung Health and Infection in Cystic Fibrosis LifeArc and Cystic Fibrosis Trust have launched the…
-
News releasesLifeArc launches UK’s first cystic fibrosis Innovation Hub Network
The UK’s first network of Cystic Fibrosis Lung Health Innovation Hubs is being launched to accelerate the development of new…
-

AIRNET: A clinical trial to find new treatments for bronchiectasis
AIRNET: A clinical trial to find new treatments for bronchiectasis We have partnered with EMBARC and the University of Dundee…
-
News releasesFirst awardees of £3m collaborative Drug Discovery Programme are announced
The Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate has announced the first cohort of awardees of its Collaborative Discovery Programme…
-
News releasesDrug trial offers hope to 200,000 people with ‘hidden’ lung condition
A multi-million-pound clinical trial, funded by LifeArc, to find out whether existing drugs could be used to treat people with…
-
BlogsRaising awareness of NTM pulmonary disease and its new Standards of Care
Today, 4 August is World Non-Tuberculous Mycobacteria (NTM) Awareness Day. A couple of years ago I had never heard of…
-
ArticlesBronchiectasis: an overlooked lung condition with untapped commercial and research potential
Bronchiectasis (BE) is a chronic lung condition that significantly impacts the lives of many people in the UK and around…
-

Bronchiectasis: a neglected and overlooked lung condition with unrealised commercial potential
Bronchiectasis: a neglected and overlooked lung condition with unrealised commercial potential We are collaborating with industry experts and Asthma +…
-

Accelerating CF Research
Accelerating CF Research: Strategies for rapidly progressing your science to clinical impact Join us at our industry symposium and unlock…
-

Funding: CF AMR Syndicate funding call for new cystic fibrosis therapies
Funding: CF AMR Syndicate funding call for new cystic fibrosis therapies LifeArc, as part of the CF AMR Syndicate, is…
-

Funding: Drug repurposing call to treat chronic respiratory infection
Funding: Drug repurposing call to treat chronic respiratory infection LifeArc has committed £10m to fund up to five consortia programmes…

